Disclosed are indole compounds represented by general formula (I). An example of the compound of formula (I) is: ({ [(1Z)-2,2-diethyl-1-oxidohydrazono]amino} oxy)methyl 3-{ [({ 2-chloro-5-[(2-methyl-5-nitro-2,3-dihydro-1H-indol-I-yl)carbamoyl]phenyl} sulphonyl)amino ]methyl} benzoate. The compounds of formula (I) are used to treat hypertension and cardiovascular pathologies and complications such as retinopathy, cerebral accidents, dementia, left ventricular hypertrophy, cardiac insufficiency, angina pectoris, myocardial infarction, nephropathy, cerebral and coronary accidents, arteritis, vasculopathies, vascular complications of disorders such as diabetes, obesity, metabolic syndrome, cancer or fibrosis of the liver and for the treatment of hypertension of pulmonary, ocular or portal origin.
